MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 45 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,310 | -93.7% | 12,347 | -84.1% | 0.00% | – |
| Q2 2023 | $116,342 | +78.2% | 77,561 | +104.3% | 0.00% | – |
| Q1 2023 | $65,303 | -69.4% | 37,967 | -79.6% | 0.00% | – |
| Q4 2022 | $213,550 | -71.3% | 185,695 | -34.9% | 0.00% | – |
| Q3 2022 | $745,000 | -57.9% | 285,461 | -65.0% | 0.00% | – |
| Q2 2022 | $1,771,000 | -58.2% | 816,318 | -10.2% | 0.00% | -100.0% |
| Q1 2022 | $4,234,000 | +12.2% | 908,576 | +45.8% | 0.00% | – |
| Q4 2021 | $3,775,000 | -21.5% | 623,034 | -6.8% | 0.00% | -100.0% |
| Q3 2021 | $4,811,000 | +6.9% | 668,151 | -6.5% | 0.00% | 0.0% |
| Q2 2021 | $4,500,000 | – | 714,251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Praetorian Wealth Management, Inc. | 200,000 | $118,400 | 0.04% |
| Atlas Brown,Inc. | 43,500 | $25,752 | 0.01% |
| Taylor & Morgan Wealth Management, LLC | 16,086 | $9,523 | 0.01% |
| Fidelis Capital Partners, LLC | 38,590 | $22,845 | 0.01% |
| Cambria Investment Management, L.P. | 171,570 | $101,569 | 0.01% |
| Corundum Group, Inc. | 19,600 | $11,603 | 0.01% |
| Bridgecreek Investment Management, LLC | 30,000 | $17,760 | 0.00% |
| XTX Topco Ltd | 39,544 | $23,410 | 0.00% |
| WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC | 14,000 | $8,288 | 0.00% |
| NWAM LLC | 40,000 | $23,680 | 0.00% |